Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M309Revenue (TTM) $M21.0Net Margin (%)-1,006.0Altman Z-Score-4.7
Enterprise Value $M439EPS (TTM) $-0.8Operating Margin %-948.8Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)-1,006.0Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %3.0Quick Ratio3.5Cash flow > EarningsY
Price/Sales13.65-y EBITDA Growth Rate %42.7Current Ratio3.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-50.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1,599.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M294ROIC % (ttm)-287.3Gross Margin Increase y-yN

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

NVAX is held by these investors:

NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
YOUNG JAMES FDirector 2017-08-31Sell175,000$1.06-0.94view
PHILLIPS BARCLAY ASVP, CFO 2017-07-31Buy2,057$0.8917.98view
MCMANUS MICHAEL A JRDirector 2017-05-12Buy20,000$0.978.25view
PHILLIPS BARCLAY ASVP, CFO 2017-05-11Buy25,000$0.8425view
Erck Stanley CPresident and CEO 2017-05-11Buy50,000$0.8425view
MCMANUS MICHAEL A JRDirector 2017-05-11Buy10,000$0.8425view
DOUGLAS RICHARDDirector 2017-05-11Buy200,000$0.9312.9view
YOUNG JAMES FDirector 2017-03-14Sell100,000$1.39-24.46view
Trizzino JohnSVP, Commercial Operations 2017-01-31Buy3,401$1.12-6.25view
Herrmann John A IIISVP, General Counsel 2017-01-31Buy4,960$1.12-6.25view

Quarterly/Annual Reports about NVAX:

News about NVAX:

Articles On GuruFocus.com
Novavax Announces Leadership Change Oct 13 2017 
Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference Sep 19 2017 
Novavax Initiates Phase 1/2 Trial of NanoFlu™ Vaccine in Older Adults Sep 19 2017 
Novavax to Participate in the Citi 12th Annual Biotech Conference Sep 05 2017 
Novavax Reports Second Quarter 2017 Financial Results Aug 08 2017 
Novavax to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on Augu Aug 01 2017 
Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for Jul 24 2017 
Genocea Reports Positive Top-Line 12-Month Phase 2b Data for GEN-003 in Genital Herpes Jul 24 2017 
Reminder: Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4: Jul 21 2017 
Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4:30 PM Jul 17 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat